We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£325.00
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
Price data last checked 32 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£325 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 59 days · 59 data points (no recent data)
Price Distribution
Price distribution over 59 days • 1 price levels
Price Analysis
Most common price: £325 (59 days, 100.0%)
Price range: £325 - £325
Price levels: 1 different prices over 59 days
Product Specifications
- Format
- paperback
- ASIN
- B00EA0H5QI
- Domain
- Amazon UK
- Release Date
- 17 July 2013
- Listed Since
- 01 August 2013
Similar Products You Might Like
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
Price unavailable
The 2013-2018 Outlook for Lymphoma Therapeutics in Africa
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
The 2023-2028 Outlook for Chronic Myelogenous Leukemia Treatments for US Zip Codes
The 2016-2021 Outlook for Hematology and Oncology Products in India
The 2013-2018 Outlook for Melanoma Therapeutics in India
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
The 2016-2021 Outlook for Cancer Therapies in Asia
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
